Control of regulatory T (Treg) cell function by protein kinase C-eta (PKC.): A novel target for cancer immunotherapy

被引：0
|
作者：
Pedros, Christophe
Kong, Kok-Fai
Altman, Amnon
机构：
来源：
CANCER IMMUNOLOGY RESEARCH | 2016年 / 4卷 / 11期
关键词：
D O I：
10.1158/2326-6066.IMM2016-A148
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A148
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Control of regulatory T (Treg) cell function by protein kinase C-eta (PKCη): A novel target for cancer immunotherapy
    Pedros, Christophe
    Kong, Kok-Fai
    Altman, Amnon
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [2] Control of regulatory T (Treg) cell function by protein kinase C-eta (PKCη): A novel target for cancer immunotherapy
    Pedros, Christophe
    Kong, Kok-Fai
    Altman, Amnon
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [3] Protein kinase C-eta (PKCη) is dispensable for the activation and function of CD8+T cells
    Liu, Hsin Yu
    Pedros, Christophe
    Balancio, Ann J. Canonigo
    Altman, Amnon
    JOURNAL OF IMMUNOLOGY, 2019, 202 (01):
  • [4] Protein kinase C-eta as a possible therapeutic target in breast cancer
    Livneh, Etta
    Karp, Galia
    Oberkovitz, Galia
    Rotem, Noa
    Abughanem, Sara
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 407 - 408
  • [5] Protein kinase C-eta as a therapeutic target in breast cancer.
    Livneh, E
    Karp, G
    Oberkovitz, G
    Rotem, N
    Maissel, A
    Shahaf, G
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9111S - 9111S
  • [6] Pharmacological inhibition of protein kinase C-eta inactivates the contact-dependent suppressive activity of regulatory T cells (Tregs): A novel approach for cancer immunotherapy?
    Xie, Jiji
    Liu, Hsin-Yu
    Pedros, Christophe
    Kong, Kok-Fai
    Altman, Amnon
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [7] Potential roles of protein kinase C-eta in T cell activation.
    Resnick, MS
    Luo, X
    Sando, JJ
    FASEB JOURNAL, 1996, 10 (06): : 2583 - 2583
  • [8] Protein kinase C-eta is required for Treg-mediated suppression of anti-tumor and viral immunity
    Liu, Hsin-Yu
    Pedros, Christophe
    Balancio, Ann
    Kong, Kok-Fai
    Altman, Amnon
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [9] Phosphoinositide 3-kinaseδ is a regulatory T-cell target in cancer immunotherapy
    Lim, Ee Lyn
    Okkenhaug, Klaus
    IMMUNOLOGY, 2019, 157 (03) : 210 - 218
  • [10] The protein kinase C inhibitor sotrastaurin allows regulatory T cell function
    de Weerd, A.
    Kho, M.
    Kraaijeveld, R.
    Zuiderwijk, J.
    Weimar, W.
    Baan, C.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 175 (02): : 296 - 304
12345